These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6118940)

  • 1. The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn's disease.
    Danielsson D; Kjellander J; Järnerot G
    Scand J Gastroenterol; 1981; 16(2):183-92. PubMed ID: 6118940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metronidazole and sulfasalazine on the normal human faecal flora.
    Krook A
    Scand J Gastroenterol; 1981; 16(5):587-92. PubMed ID: 6119764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora.
    Krook A; Järnerot G; Danielsson D
    Scand J Gastroenterol; 1981; 16(4):569-75. PubMed ID: 6119763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the fecal flora of patients with Crohn's disease during treatment with metronidazole. A preliminary report.
    Krook A; Danielsson D; Kjellander J; Järnerot G
    Scand J Gastroenterol; 1979; 14(6):705-10. PubMed ID: 231297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.
    Krook A; Lindström B; Kjellander J; Järnerot G; Bodin L
    J Clin Pathol; 1981 Jun; 34(6):645-50. PubMed ID: 7251906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of bacteroides species to metronidazole during treatment of patients with Crohn's disease and healthy individuals.
    Krook A; Kjellander J; Danielsson D
    Scand J Infect Dis; 1982; 14(1):45-8. PubMed ID: 7071526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy.
    Hudson MJ; Hill MJ; Elliott PR; Berghouse LM; Burnham WR; Lennard-Jones JE
    J Med Microbiol; 1984 Dec; 18(3):335-45. PubMed ID: 6334160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    West B; Lendrum R; Hill MJ; Walker G
    Gut; 1974 Dec; 15(12):960-5. PubMed ID: 4155692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients.
    Mitelman F; Strömbeck B; Ursing B; Nordle O; Hartley-Asp B
    Hereditas; 1982; 96(2):279-86. PubMed ID: 6125490
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R; Walker JG; West B; Hill MJ
    Gut; 1974 Apr; 15(4):344. PubMed ID: 4151868
    [No Abstract]   [Full Text] [Related]  

  • 12. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.
    Favier C; Neut C; Mizon C; Cortot A; Colombel JF; Mizon J
    Dig Dis Sci; 1997 Apr; 42(4):817-22. PubMed ID: 9125655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects.
    Ruseler-van Embden JG; Both-Patoir HC
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):125-32. PubMed ID: 6614898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of fecal flora and its correlation with inflammatory indicators in patients with inflammatory bowel disease].
    Zhang T; Chen Y; Wang Z; Zhou Y; Zhang S; Wang P; Xie S; Jiang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1474-7. PubMed ID: 24144750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of metronidazole with phenobarbital, cimetidine, prednisone, and sulfasalazine in Crohn's disease.
    Eradiri O; Jamali F; Thomson AB
    Biopharm Drug Dispos; 1988; 9(2):219-27. PubMed ID: 2897213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives.
    Van de Merwe JP; Schröder AM; Wensinck F; Hazenberg MP
    Scand J Gastroenterol; 1988 Nov; 23(9):1125-31. PubMed ID: 3247591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics and differential diagnosis of intestinal flora in Crohn's disease and intestinal tuberculosis].
    Liu X; Cui Y; Ouyang C; Li X; Lu F; Wu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1196-200. PubMed ID: 21131744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
    Gosselink MP; Schouten WR; van Lieshout LM; Hop WC; Laman JD; Ruseler-van Embden JG
    Dis Colon Rectum; 2004 Sep; 47(9):1519-25. PubMed ID: 15486751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group.
    Peach S; Lock MR; Katz D; Todd IP; Tabaqchali S
    Gut; 1978 Nov; 19(11):1034-42. PubMed ID: 730070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
    Rosén A; Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O
    Gastroenterology; 1982 Sep; 83(3):541-9. PubMed ID: 6124473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.